Bal Pharma Limited (NSE:BALPHARMA)

Bal Pharma Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 24, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	1,147	1,314	1,432	1,050	1,599	797
Market Cap Growth	-41.02%	-8.20%	36.34%	-34.31%	100.65%	72.70%
Enterprise Value	2,604	2,637	2,758	2,031	2,587	1,830
Last Close Price	71.87	82.78	89.18	64.88	103.37	50.96
PE Ratio	16.80	18.22	19.37	40.83	28.49	16.80
PS Ratio	0.39	0.43	0.42	0.35	0.57	0.32
PB Ratio	1.46	1.70	1.99	1.65	2.73	1.49
P/TBV Ratio	1.85	1.81	2.14	1.79	2.93	1.60
P/FCF Ratio	23.53	86.00	12.11	-	8.72	4.20
P/OCF Ratio	5.98	6.47	6.28	-	5.97	3.57
EV/Sales Ratio	0.88	0.87	0.81	0.67	0.92	0.73
EV/EBITDA Ratio	10.52	10.23	9.75	8.54	11.77	7.49
EV/EBIT Ratio	14.66	13.17	12.75	11.66	17.33	10.81
EV/FCF Ratio	53.45	172.55	23.32	-	14.12	9.65
Debt / Equity Ratio	1.98	1.97	1.98	2.09	1.82	2.12
Debt / EBITDA Ratio	6.26	5.61	4.84	5.40	4.68	4.48
Debt / FCF Ratio	31.79	99.67	12.03	-	5.82	5.97
Asset Turnover	0.86	0.93	1.07	1.06	1.12	1.05
Inventory Turnover	1.58	1.71	2.13	2.07	2.56	2.41
Quick Ratio	0.44	0.48	0.61	0.50	0.52	0.50
Current Ratio	1.07	1.07	1.15	1.09	1.11	1.08
Return on Equity (ROE)	9.33%	9.69%	10.98%	4.29%	10.20%	9.55%
Return on Assets (ROA)	3.22%	3.82%	4.27%	3.80%	3.73%	4.42%
Return on Capital (ROIC)	4.84%	5.64%	6.58%	6.02%	5.63%	6.34%
Return on Capital Employed (ROCE)	14.70%	17.20%	18.50%	16.80%	15.70%	19.30%
Earnings Yield	5.95%	5.49%	5.16%	2.45%	3.51%	5.95%
FCF Yield	4.25%	1.16%	8.26%	-15.41%	11.46%	23.81%
Dividend Yield	1.62%	1.45%	1.35%	1.54%	0.97%	1.96%
Payout Ratio	-	26.48%	21.22%	60.55%	26.41%	-
Buyback Yield / Dilution	1.61%	-0.74%	-0.30%	-5.86%	-4.39%	-0.19%
Total Shareholder Return	3.23%	0.71%	1.05%	-4.32%	-3.42%	1.77%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.